Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla

Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 4 Completed 1 Terminated 1

Sleep hormone tested to halt debilitating MS progression

Disease control Terminated

This study aimed to see if adding the hormone melatonin to the standard drug ocrelizumab could safely help slow down disability in people with a fast-progressing form of multiple sclerosis (MS). It involved 25 adults with primary progressive MS who were already stable on ocrelizu…

Phase: PHASE1, PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC